SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 10-QSB
X QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
For the quarterly period ended September 30, 1997
OR
____ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
For the transition period from _______________ to ______________
Commission file number 0-3207
Barringer Technologies Inc.
(EXACT NAME OF SMALL BUSINESS ISSUER AS SPECIFIED IN ITS CHARTER)
Delaware 84-0720473
(STATE OR OTHER JURISDICTION OF (IRS EMPLOYER IDENTIFICATION
INCORPORATION) NUMBER)
219 South Street, Murray Hill, New Jersey 07974
(ADDRESS OF PRINCIPAL EXECUTIVE OFFICES)
(908) 665-8200
(Issuer's telephone number)
(FORMER NAME, FORMER ADDRESS AND FORMER FISCAL YEAR, IF
CHANGED SINCE LAST REPORT)
Check whether the registrant (1) filed all reports required to be filed by
Section 13 or 15(d) of the Exchange Act during the preceding 12 months (or for
such shorter period that the registrant was required to file such reports), and
(2) has been subject to such filing requirements for the past 90 days. Yes X No
State the number of shares outstanding of each of the issuer's classes of
common equity, as of the latest practicable date:
Common stock, $0.01 par value - outstanding as of October 22, 1997 - 5,492,429
shares
Transitional Small Business Disclosure Format (check one): Yes ; No X
<PAGE>
BARRINGER TECHNOLOGIES INC. AND SUBSIDIARIES
INDEX
Page No.
Part I Financial Information
Item 1. Financial Statements
- Consolidated Balance Sheets as of
September 30, 1997 (unaudited) and
December 31, 1996 3
- Consolidated Statements of Operations (unaudited)
for the three months and nine months ended
September 30, 1997 and 1996 5
- Consolidated Statements of Cash Flows (unaudited)
for the three months and nine months ended
September 30, 1997 and 1996 6
- Notes to Consolidated Financial Statements 7
Item 2. Management's Discussion and Analysis 8
Part II Other Information:
Item 6. Exhibits and Reports on Form 8-K 13
Signatures 14
Exhibits 15
<PAGE>
Item 1. Financial Statements.
BARRINGER TECHNOLOGIES INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
ASSETS September 30, December 31,
1997 1996
(unaudited)
Current assets:
Cash and cash equivalents $5,097,000 $5,276,000
Marketable securities 3,500,000 4,328,000
Trade receivables, less allowances of
$185,000 and $63,000 6,935,000 3,521,000
Inventories 3,177,000 2,270,000
Prepaid expenses and other 549,000 498,000
Deferred tax asset 1,206,000 731,000
------------- ------------
Total current assets 20,464,000 16,624,000
Machinery and equipment, net 1,368,000 595,000
Other assets 65,000 104,000
-------------- --------------
Total assets $21,897,000 $17,323,000
============== ===============
See notes to consolidated financial statements.
<PAGE>
BARRINGER TECHNOLOGIES INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
LIABILITIES AND STOCKHOLDERS' EQUITY September 30, December 31,
1997 1996
(unaudited)
Current liabilities:
Notes payable $ - $174,000
Accounts payable 944,000 1,009,000
Accrued liabilities 753,000 536,000
Accrued commissions 38,000 112,000
Accrued payroll and related taxes 815,000 522,000
----------- ------------
Total current liabilities 2,550,000 2,353,000
Other non-current liabilities 123,000 117,000
------------ ------------
Total liabilities 2,673,000 2,470,000
----------- ------------
Stockholders' equity (note 5):
Preferred stock, $2.00 par value, 4,000,000
shares authorized:
270,000 shares designated class A
convertible preferred stock, 45,146 and
60,165 shares outstanding less discount
of $35,000 and $47,000, respectively 55,000 74,000
730,000 shares designated class B
convertible preferred stock, 22,500 and
122,500 shares outstanding, respectively 45,000 245,000
Common stock, $.01 par value, 20,000,000
and 7,000,000 shares authorized,
respectively, 5,492,000 and 5,357,000
shares outstanding, respectively 55,000 54,000
Additional paid-in capital 30,148,000 29,430,000
Accumulated deficit (10,711,000) (14,522,000)
Foreign currency translation (355,000) (415,000)
Treasury stock, at cost, 31,000 shares (13,000) (13,000)
------------- ------------
Total stockholders' equity 19,224,000 14,853,000
------------- ------------
Total liabilities and stockholder's equity $21,897,000 $17,323,000
============= =============
See notes to consolidated financial statements.
<PAGE>
<TABLE>
<CAPTION>
BARRINGER TECHNOLOGIES INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
(IN THOUSANDS EXCEPT PER SHARE AMOUNTS)
(UNAUDITED)
Three Months Ended Nine Months Ended
September 30, September 30,
---------------------------- ----------------------------
1997 1996 1997 1996
------------- -------------- ------------ ---------------
<S> <C> <C> <C> <C>
Revenues $5,905 $2,340 $15,343 $7,352
Cost of revenues 2,729 1,002 6,684 3,648
------------- -------------- ------------ ---------------
Gross profit 3,176 1,338 8,659 3,704
------------- -------------- ------------ ---------------
Operating expenses:
Selling, general and administrative 1,668 919 4,868 2,560
Product development 164 34 502 91
------------- -------------- ------------ ---------------
1,832 953 5,370 2,651
------------- -------------- ------------ ---------------
Operating income 1,344 385 3,289 1,053
------------- -------------- ------------ ---------------
Other income (expense):
Investment income 99 4 311 46
Interest expense (4) (56) (9) (186)
Equity in earnings of Labco - 97 - 117
Other, net (7) (12) (30) (47)
------------- -------------- ------------ ---------------
88 33 272 (70)
------------- -------------- ------------ ---------------
Income before income tax benefit 1,432 418 3,561 983
Income tax benefit 125 125 256 125
------------- -------------- ------------ ---------------
Net income 1,557 543 3,817 1,108
Preferred stock dividend requirements (3) (11) (9) (35)
------------- -------------- ------------ ---------------
Net income attributable to common $1,554 $532 $3,808 $1,073
stockholders
============= ============== ============ ===============
Earnings per common share data (note 3):
Primary earnings per common share $ 0.24 $ 0.13 $ 0.61 $ 0.28
============= ============== ============ ===============
Fully diluted earnings per common share $ 0.24 $ 0.12 $ 0.61 $ 0.26
============= ============== ============ ===============
Weighted average common and common
equivalent shares outstanding:
Primary 6,366 4,164 6,244 3,898
============= ============== ============ ===============
Fully diluted 6,389 4,619 6,268 4,391
============= ============== ============ ===============
See notes to consolidated financial statements.
</TABLE>
<PAGE>
<TABLE>
<CAPTION>
BARRINGER TECHNOLOGIES INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
(IN THOUSANDS) (UNAUDITED)
Three Months Ended Nine Months Ended
September 30, September 30,
------------------------------- ----------------------------
OPERATING ACTIVITIES 1997 1996 1997 1996
------------- ----------- ------------- --------------
<S> <C> <C> <C> <C>
Net Income $1,557 $543 $3,817 $1,108
Items not affecting cash:
Depreciation and amortization 40 90 120 165
Deferred tax benefit (175) (160) (475) (160)
Receivable reserve 65 - 159 -
Income from unconsolidated investment - (97) - (117)
Other 86 19 73 37
Increase in non-cash working capital balances (443) (526) (3,859) (1,609)
------------- ----------- ----------- ------------
Cash provided by (used in) operating 1,130 (131) (165) (576)
activities
------------- ----------- ----------- ------------
INVESTING ACTIVITIES
Purchase of equipment and other (642) (38) (1,155) (85)
Sale of marketable securities 555 - 828 -
Decrease in investment in operation held for sale
- 21 - -
------------- ----------- ----------- -----------
Cash (used in) investing activities (87) (17) (327) (85)
------------- ----------- ----------- -----------
FINANCING ACTIVITIES
Proceeds on sale of securities and other 158 1,000 422 1,000
Repayment of 121/2% debentures - (300) - (300)
Repayment of stockholder loan - - 71 -
Payment of dividends on preferred stock - - (6) -
Increase (reduction) in bank debt and - (371) (174) 116
other
------------- ----------- ----------- -----------
Cash provided by financing activities 158 329 313 816
------------- ----------- ----------- -----------
Increase (decrease) in cash and equivalents 1,201 181 (179) 155
Cash and equivalents at beginning of period 3,896 17 5,276 43
------------- ----------- ----------- -----------
Cash and equivalents at end of period $5,097 $198 $5,097 $ 198
============= =========== =========== ===========
CHANGES IN COMPONENTS OF NON-CASH WORKING CAPITAL
BALANCES
Receivables $(648) $622 $(3,573) $ (503)
Inventory 548 (644) (606) (675)
Other current assets (54) (85) (51) (111)
Accounts payable and accrued liabilities (289) (419) 371 (320)
------------- ----------- ---------- ------------
Increase in non-cash working capital balances $(443) $ (526) $(3,859) $(1,609)
============= =========== ========== ============
$15 $ 52 $ 17 $ 159
Cash paid during the period for interest
============= =========== ========== ============
Cash paid during the period for income taxes $28 $ 14 $ 186 $ 14
============= =========== ========== ============
See notes to consolidated financial statements.
</TABLE>
<PAGE>
BARRINGER TECHNOLOGIES INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
1. In the opinion of the Company, the unaudited consolidated financial
statements contain all adjustments (consisting of only normal recurring
accruals) necessary to present fairly the consolidated financial position of the
Company as of September 30, 1997 and the results of its operations and its cash
flows for the three months and nine months ended September 30, 1997 and 1996,
respectively. The accounting policies followed by the Company are set forth in
the Notes to Consolidated Financial Statements in the audited consolidated
financial statements of Barringer Technologies Inc. and Subsidiaries included in
its Annual Report on Form 10-KSB for the year ended December 31, 1996. This
report should be read in conjunction therewith. The results of operations for
the interim periods are not necessarily indicative of the results to be expected
for any other interim period or for the full year.
2. As a result of the Company's prior historical trend of losses, a valuation
allowance has been provided for a substantial portion of the deferred tax
assets. At December 31, 1996, the net deferred tax asset of $731,000, included
approximately $525,000 and $206,000 related to the Company's Canadian and U.S.
operations, respectively. At September 30, 1997, the net deferred tax asset of
$1,206,000 included approximately $525,000 and $681,000 related to the Company's
Canadian and U.S. operations, respectively. Based on historical results and
estimated 1997 and 1998 earnings, which include earnings from certain contracts,
as well as available tax planning strategies, management considers realization
of the unreserved deferred tax asset more likely than not. Additional reductions
to the valuation allowance will be recorded in future periods where, in the
opinion of management, the Company's ability to generate taxable income is
considered more likely than not.
3 Primary earnings per common share is computed by dividing net income, less
preferred stock dividends, by the weighted average number of common and common
equivalent shares outstanding during the period. Common equivalent shares
consist of the dilutive effect, if any, of unissued shares under options and
warrants, computed using the treasury stock method (using the average stock
prices for primary basis and the higher of average or period-end stock prices
for fully diluted basis). Fully diluted earnings per common share is computed
assuming the conversion of convertible preferred stock at the beginning of the
period or the date of issuance, whichever is later.
4. On February 28, 1997, the Company's Board of Directors granted options to 13
officers, directors and key employees, to acquire 135,500 shares of the
Company's common stock at $9.375 per share, which was the fair value of the
stock on the date of grant. On April 15, 1997, the Company's Board of Directors
granted an option to a key employee, to acquire 5,000 shares of the Company's
common stock at $11.25 per share, which was the fair value of the stock on the
date of grant. In addition, on May 13, 1997, pursuant to the terms of the
Company's Independent Director Plan, options to acquire 12,000 shares of the
Company's common stock at $13.875 per share, which was the fair value of the
stock on the date of grant, were issued to the Company's independent directors.
Compensation expense related to the options granted to Directors totaled $45,000
through September 30, 1997.
5. On August 7, 1997, the Company filed with the Securities and Exchange
Commission a registration statement relating to a proposed underwritten public
offering by the Company of 2,000,000 shares of its Common Stock. On September
25, 1997, the Company announced that it had postponed its planned offering in
light of current market conditions. In the event that the Company does not
complete the proposed offering, the Company will expense the related costs that
are currently capitalized as deferred offering costs.
<PAGE>
Item 2. Management's Discussion and Analysis
BARRINGER TECHNOLOGIES INC. AND SUBSIDIARIES
MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS
The following table sets forth certain income and expense items from
the Company's consolidated statements of operations expressed as a percentage of
revenues for the periods indicated.
<TABLE>
Percentage of Revenues
Three months ended Nine months ended
September 30, September 30,
1997 1996 1997 1996
------- ---- ---- ----
Statement of operations data:
<S> <C> <C> <C> <C>
Revenues........................................ 100.0 100.0 100.0 100.0
Cost of revenues................................ 46.2 42.8 43.6 49.6
---------- ---------- ---------- -------
Gross profit.................................... 53.8 57.2 56.4 50.4
Selling, general and administrative expenses 28.2 39.3 31.7 34.8
Product development............................. 2.8 1.4 3.3 1.2
---------- ---------- ---------- -------
Operating income ............................... 22.8 16.5 21.4 14.4
Other income (expense), net..................... 1.5 1.4 1.8 (1.0)
Income tax benefit ............................. 2.1 5.3 1.7 1.7
---------- ---------- ---------- -------
Net income ..................................... 26.4 23.2 24.9 15.1
Preferred stock dividend requirements........... (0.1) (0.5) (0.1) (0.5)
---------- ---------- ---------- -------
Net income attributable to common 26.3 22.7 24.8 14.6
stockholders.................................
========== ========== ========== =======
</TABLE>
Comparison of the Three-Month Period Ended September 30, 1997 to the Three-Month
Period Ended September 30, 1996
Revenues. For the three months ended September 30, 1997, revenues increased
by $3.6 million, or 152%, to $5.9 million from $2.3 million in the comparable
period ended September 30, 1996. Sales of IONSCAN(R)s and related products
increased by $3.4 million, or 151%, due to an increase of 206% in the number of
units sold, offset in part by a decline in the average unit selling price. The
increase in unit sales was due to significant IONSCAN(R) sales to the aviation
security sector as well as sales to the U.S. Coast Guard, the National Guard
Bureau and, to a lesser extent, increased sales in other markets. The decrease
in average selling prices resulted primarily from an increase in the number of
IONSCAN(R)s sold to U.S. government agencies, which typically are at lower unit
prices than sales to other customers. Revenues from specialty instruments were
insignificant for the quarter. Revenues derived from funded research and
development increased by approximately $183,000 , or 197%, in the three months
ended September 30, 1997 as compared to the same period in 1996. Funded research
revenues increased as the Company continued its work on a Federal Aviation
Administration (" FAA") contract, awarded in April 1997, the first phase of
which is expected to be completed in the first quarter of 1998.
<PAGE>
As sales of its IONSCAN(R)s have increased, the Company has placed less emphasis
on marketing of specialty instruments and contract research and development. As
a result, management anticipates that revenues from those activities will become
increasingly less important to the Company's overall results of operations.
During the period ended September 30, 1997, the Company substantially
completed the deployment of the FAA's initial order for 50 IONSCAN(R)s, which
had a significant positive impact on the Company's results for the third quarter
and the recently concluded nine-month period. Based upon reported field results,
the IONSCAN(R) is performing to the Company's expectations. Accordingly, the
Company believes that it is properly positioned to participate in any future FAA
orders for trace detection equipment. While the FAA has indicated its intention
to continue deployment of trace detection equipment, there can be no assurance
that subsequent orders will be received in 1997 and may move into 1998.
Additionally there can be no assurance as to the size of any such orders.
Gross Profit. For the three months ended September 30, 1997, gross profit
increased by $1.9 million, or 137%, to $3.2 million from $1.3 million in the
comparable 1996 period. As a percentage of revenues, gross profit decreased to
53.8% in the 1997 period from 57.2% in the comparable 1996 period. The decrease
was primarily attributable to the mix of sales being dominated by large U.S.
governmental orders at lower selling prices.
Selling, General and Administrative. For the three months ended September
30, 1997, selling, general and administrative expenses increased by $749,000, or
81.5%, to $1.7 million from $919,000 in the comparable 1996 period. Selling and
marketing expenses increased by approximately $290,000, of which approximately
$75,000 was due to increased sales commissions attributable to a larger
percentage of sales originating through independent sales agents and
distributors during the period. The remaining increase was attributable to the
addition of sales and service personnel and related costs to handle increased
business volume. General and administrative expenses increased by $459,000,
primarily as a result of increased payroll and related costs and increased
professional and consulting costs. As a percentage of revenues, selling, general
and administrative expenses decreased to 28.2% in the 1997 period from 39.3% in
the comparable 1996 period primarily as a result of spreading the increased
costs over a larger revenue base.
Product Development. For the three months ended September 30, 1997, product
development expenses increased by $130,000, or 382%, to $164,000 from $34,000 in
the comparable 1996 period. As a percentage of revenues, product development
expenses increased to 2.8% (7.5% when combined with funded research and
development) in the 1997 period from 1.4% (5.4% when combined with funded
research and development) in the comparable 1996 period as a result of a higher
level of internally funded new product development activity. Management expects
to incur increased product development expenses in future periods in connection
with the enhancement of existing products and the development of new products
and applications.
Other Income and Expense. For the three months ended September 30, 1997,
interest expense decreased by $52,000, or 92.9%, to $4,000 from $56,000 in the
comparable 1996 period as a result of the repayment of indebtedness out of the
net proceeds of the Company's November 1996 public offering.
Investment income for the three months ended September 30, 1997 was $99,000
as compared to $4,000 for the same period in 1996, primarily as a result of the
investment of a portion of the net proceeds from the Company's November 1996
public offering.
Income Taxes. In the three-month period ended September 30, 1997, the
Company had a net tax benefit of $125,000, composed of current foreign taxes of
$50,000, offset by a $175,000 net U.S. deferred tax benefit as compared to a net
tax benefit of $125,000, composed of current foreign taxes of $35,000, offset by
a $160,000 net U.S. deferred tax benefit in the comparable 1996 period. Such
deferred tax benefits were due in part to a reduction in the deferred tax
valuation allowance as a result of changes in management's estimates of the
utilization of both U.S. and Canadian tax loss carryforwards caused primarily by
improved operating results. Management anticipates that further deferred tax
benefits will be recognized in 1997.
Comparison of the Nine-Month Period Ended September 30, 1997 to the Nine-Month
Period Ended September 30, 1996
Revenues. For the nine months ended September 30, 1997, revenues increased
by $7.9 million, or 109%, to $15.3 million from $7.4 million in the comparable
period ended September 30, 1996. Sales of IONSCAN(R)s and related products
increased by $8.6 million, or 143%, due to an increase of 186% in the number of
units sold, offset in part by a decline in the average unit selling price. The
increase in unit sales was due to significant IONSCAN(R) sales to the aviation
security sector, including the FAA, the Mexican Aeropuertos y Servicios
Auxiliares, the Kuala Lampur Airport and the BAA, in addition to large unit
sales made to the Army National Guard Bureau, the U.S. Coast Guard and, to a
lesser extent, increased sales in other markets. The decrease in average selling
prices resulted primarily from an increase in the number of IONSCAN(R)s sold to
U.S. government agencies, which typically are at lower unit prices than sales to
other customers. Sales of specialty instruments decreased by approximately
$583,000, or 84.6%, in the nine months ended September 30, 1997 as compared to
the same period in 1996, principally due to the completion of a heavy water
analyzer contract, which was awarded to the Company in mid-1995 and completed in
the first half of 1996. Revenues derived from funded research and development
decreased by approximately $44,000, or 7.0%, in the nine months ended September
30, 1997 as compared to the same period in 1996. Funded research revenues
declined as the Company redirected its research and development resources to
product application and development and in support of increased production. As
sales of its IONSCAN(R)s have increased, the Company has placed less emphasis on
marketing of specialty instruments and contract research and development. As a
result, management anticipates that revenues from those activities will become
increasingly less important to the Company's overall results of operations.
During the period ended September 30, 1997, the Company substantially
completed the deployment of the FAA's initial order for 50 IONSCAN(R)s, which
had a significant positive impact on the Company's results for the third quarter
and the recently concluded nine-month period. Based upon reported field results,
the IONSCAN(R) is performing to the Company's expectations. Accordingly, the
Company believes that it is properly positioned to participate in any future FAA
orders for trace detection equipment. While the FAA has indicated its intention
to continue deployment of trace detection equipment, there can be no assurance
that subsequent orders will be received in 1997 and may move into 1998.
Additionally there can be no assurance as to the size of any such orders.
Gross Profit. For the nine months ended September 30, 1997, gross
profit increased by $5.0 million, or 134%, to $8.7 million from $3.7 million in
the comparable 1996 period. As a percentage of revenues, gross profit increased
to 56.4% in the 1997 period from 50.4% in the comparable 1996 period. The
increase in gross margin was primarily attributable to higher margins on
international sales, coupled with larger, more efficient production runs of the
IONSCAN(R), offset in part by lower margins on sales to U.S. government
agencies. In addition, the Company has been able to reduce its cost of materials
as a result of higher volume purchases.
Selling, General and Administrative. For the nine months ended September
30, 1997, selling, general and administrative expenses increased by $2.3
million, or 90.2%, to $4.9 million from $2.6 million in the comparable 1996
period. Selling and marketing expenses increased by approximately $1.3 million,
of which $741,000 was due to increased sales commissions attributable to a
larger percentage of sales originating through independent sales agents and
distributors during the period. The remaining increase was attributable to the
addition of sales and service personnel and related costs to handle increased
business volume. General and administrative expenses increased by $1.0 million ,
primarily as a result of increased payroll and related costs and increased
professional and consulting costs. As a percentage of revenues, selling, general
and administrative expenses decreased to 31.7% in the 1997 period from 34.8% in
the comparable 1996 period primarily as a result of spreading the increased
costs over a larger revenue base.
Product Development. For the nine months ended September 30, 1997, product
development expenses increased by $411,000, or 452%, to $502,000 from $91,000 in
the comparable 1996 period. As a percentage of revenues, product development
expenses increased to 3.3% (7.1% when combined with funded research and
development) in the 1997 period from 1.2% (9.8% when combined with funded
research and development) in the comparable 1996 period as a result of a higher
level of internally funded new product development activity. Management expects
to incur increased product development expenses in future periods in connection
with the enhancement of existing products and the development of new products
and applications.
Other Income and Expense. For the nine months ended September 30, 1997,
interest expense decreased by $177,000, or 95.2%, to $9,000 from $186,000 in the
comparable 1996 period as a result of the repayment of indebtedness out of the
net proceeds of the Company's November 1996 public offering.
Investment income for the nine months ended September 30, 1997 was $311,000
as compared to $46,000 for the same period in 1996, primarily as a result of the
investment of a portion of the net proceeds from the Company's November 1996
public offering. In the nine months ended September 30, 1996, the Company
recorded $46,000 of gains recognized on trading securities held for Canadian
pension funding purposes.
Income Taxes. In the nine-month period ended September 30, 1997, the
Company had a net tax benefit of $256,000, composed of current foreign taxes of
$219,000, offset by a $475,000 net U.S. deferred tax benefit as compared to a
net tax benefit of $125,000, composed of current foreign taxes of $35,000,
offset by a $160,000 net U.S. deferred tax benefit in the comparable 1996
period. Such deferred tax benefits were due in part to a reduction in the
deferred tax valuation allowance as a result of changes in management's
estimates of the utilization of both U.S. and Canadian tax loss carryforwards
caused primarily by improved operating results. Management anticipates that
further deferred tax benefits will be recognized in 1997.
<PAGE>
Liquidity and Capital Resources
Cash used in operations was $165,000 for the nine months ended
September 30, 1997 as compared to $576,000 in the same period in 1996. However,
for the three months ended September 30, 1997, the Company generated cash from
operations of $1.1 million as compared to cash used in operations of $131,000 in
the same period in 1996. Cash used in the first nine months of 1997 resulted
primarily from a significant increase in accounts receivable and inventories,
which more than offset net income of $3.8 million. Accounts receivable increased
as a result of higher sales, particularly during the latter portion of the month
of August and the month of September. Inventories also increased as the Company
acquired the materials necessary to support increased IONSCAN(R) production
during the first nine months of 1997. Cash used in operating activities during
1996 resulted primarily from increases in accounts receivable and inventory,
which more than offset net income of $1,108,000 for the same period in 1996.
Net cash used in investing activities was $327,000 for the first nine
months of 1997 and $85,000 for the same period in 1996. Cash used in investing
activities during the first nine months of 1997 resulted primarily from capital
expenditures of $1.2 million offset in part by the sale of investments. Cash
used in investing activities during the same period in 1996 resulted primarily
from capital expenditures of $85,000.
Cash provided by financing activities was $313,000 for the first nine
months of 1997 and $816,000 for the same period in 1996. Cash provided by
financing activities during the first nine months of 1997 resulted primarily
from the net proceeds of certain option and warrant exercises, offset in part by
the repayment of indebtedness. Cash provided by financing activities in the same
period in 1996 resulted primarily from the sale of securities offset in part by
the repayment of debt.
The Company's capital expenditures for the nine months ended September 30,
1997 aggregated $1.2 million. Such expenditures consisted primarily of software
upgrades to various manufacturing information systems, computer hardware
modernization relating to the Company's network system and the acquisition of
additional equipment. The Company anticipates that capital expenditures will
approximate $150,000 for the fourth quarter of 1997. Also, the Company believes
that it will require approximately $1.0 million in additional investment in
tooling, equipment, fixtures and facility to meet its anticipated production
levels for 1998.
As of September 30, 1997, the Company had cash and cash equivalents of $5.1
million and marketable securities of $3.5 million.
The Company has substantial tax loss carryforwards to offset future tax
liabilities in the U.S.
Inflation
Inflation was not a material factor in either the sales or the operating
expenses of the Company during the periods presented herein.
Recent Pronouncements of the Financial Accounting Standards Board
In February 1997, the Financial Accounting Standards Board ("FASB") issued
Statement of Financial Accounting Standards No. 128, "Earnings Per Share" ("SFAS
128") which establishes standards for computing and presenting earnings per
share. SFAS 128 replaces the presentation of primary earnings per share and
fully diluted earnings per share with basic earnings per share and diluted
earnings per share, respectively. Basic earnings per share excludes dilution and
is computed by dividing income available to common stockholders by the weighted
average number of common shares outstanding for the period. Diluted earnings per
share is computed similarly to fully diluted earnings per share. The standard is
effective for financial statements for periods ending after December 15, 1997,
with earlier application not permitted.
Basic and diluted earnings per share using this standard would have been
$0.28 and $0.24 and $0.70 and $0.61, respectively, for the three months and nine
months ended September 30, 1997, respectively, and $0.15 and $0.12 and $0.31 and
$0.26, respectively, for the three months and nine months ended September 30,
1996, respectively.
In June 1997, the FASB issued Statement of Financial Accounting Standards
No. 130, "Reporting
<PAGE>
Comprehensive Income," which establishes standards for reporting and display of
comprehensive income and its components in a full set of general-purpose
financial statements and will be effective for fiscal years beginning after
December 15, 1997. The Company will be reviewing this document to determine its
applicability to the Company, if any and has elected not to adopt early
application.
In June 1997, the FASB issued Statement of Financial Accounting Standards
No. 131, "Disclosures About Segments of an Enterprise and Related Information,"
which requires disclosure of reportable operating segments and will be effective
for financial statements issued for fiscal years beginning after December 31,
1997. The Company will be reviewing this pronouncement to determine its
applicability to the Company, if any.
Disclosure Regarding Forward-Looking Statements
This Form 10-QSB contains forward-looking statements within the meaning of
Section 21E of the Securities Exchange Act of 1934, as amended, including,
without limitation, statements regarding the Company's expectations for future
orders from the FAA. Although the Company believes that the expectations
reflected in such forward-looking statements are based on reasonable
assumptions, there can be no assurance that its expectations will be realized.
Forward-looking statements involve known and unknown risks that may cause the
Company's actual results for future periods to differ materially from
management's expectations. Factors that could cause results to differ materially
from the Company's expectations include, but are not limited to, the following:
general economic and political conditions, as well as conditions in the markets
for the Company's products; the Company's dependence on and the effects of
government regulation and procurement policies, including, but not limited to,
those of the FAA; the Company's dependence on large orders and the effects of
customer concentrations; the Company's dependence on its IONSCAN product, future
product development and market acceptance of the Company's products; possible
fluctuations in quarterly results and the effects of the Company's relatively
long sales cycle; the effects of competition; risks related to international
business operations; the Company's dependence on a limited number of suppliers;
and the ability of the Company to manage its growth. Further information
relating to certain of these factors is included in the Company's Registration
Statement on Form SB-2 (file no. 333-33129) and the Company's Annual Report on
Form 10-KSB for the year ended December 31, 1996 (file no. 0-3207). Other
factors may be described from time to time in the Company's other filings with
the Securities and Exchange Commission, news releases and other communications.
<PAGE>
BARRINGER TECHNOLOGIES INC. AND SUBSIDIARIES
Part II - Other Information
ITEM 6. Exhibits and Reports on Form 8-K
(a) Exhibits
3.1 The Company's Certificate of Incorporation, as amended, (previously
filed as Exhibit 3.1 to the Company's Registration Statement on Form SB-2 (File
No. 333-33129 ) and incorporated herein by reference).
3.2 By-laws of the Company (previously filed Exhibit 3.2A to the Company's
Annual Report on Form 10-K/A-2 for the fiscal year ended December 31, 1994 (File
No. 0-3207) and incorporated herein by reference).
11.1 Earnings Per Share.
27.1 Financial Data Schedule.
(b) Reports on Form 8-K
None
<PAGE>
BARRINGER TECHNOLOGIES INC. AND SUBSIDIARIES
SIGNATURES
In accordance with the requirements of the Exchange Act, the Registrant
caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized.
BARRINGER TECHNOLOGIES INC.
(Registrant)
/S/ STANLEY S. BINDER
Stanley S. Binder
President
/S/ RICHARD S. ROSENFELD
Richard S. Rosenfeld,
Chief Financial Officer
(Principal Accounting Officer)
Date: November 6, 1997
<PAGE>
BARRINGER TECHNOLOGIES INC.
INDEX TO EXHIBITS
Exhibit Number Page No.
11.1 Earnings Per Share
27.1 Financial Data Schedule
<TABLE>
<CAPTION>
EXHIBIT 11.1
BARRINGER TECHNOLOGIES INC. AND SUBSIDIARIES
EARNINGS PER COMMON SHARE
PRIMARY PER SHARE FULLY DILUTED PER SHARE
------------------------------------ --------------------------------------------
Three months ended Nine months ended Three months ended Nine months ended
September 30, September 30, September 30, September 30,
------------------ ----------------- ------------------------------------
1997 1996 1997 1996 1997 1996 1997 1996
------ ------ ------ ------ -------- ------- ------ ------
<S> <C> <C> <C> <C> <C> <C> <C> <C>
Net income $1,557 $ 543 $3,817 $1,108 $ 1,557 $ 543 $ 3,817 $ 1,108
Interest adjustment - - - - - 13 - 13
Preferred dividends (3) (11) (9) (35) (3) - (9) -
------ ------ ------- ------ -------- ------ ------ -------
Net income to common stockholders $ 1,554 $ 532 $3,808 $ 1,073 $ 1,554 $ 556 $ 3,808 $ 1,121
====== ======= ======= ======= ======== ====== ======= =======
Weighted average common shares outstanding 5,484 3,504 5,443 3,491 5,484 3,504 5,443 3,491
Assumed conversion of preferred stock - - - - 24 421 24 206
Assumed conversion of outstanding
options and warrants (treasury
stock method) 882 660 801 407 881 694 801 694
------ ----- ------ ------- -------- ----- ------- ------
Revised common share basis 6,366 4,164 6,244 3,898 6,389 4,619 6,268 4,391
====== ===== ====== ======= ======== ====== ======= ======
Earnings per common share $ 0.24 $ 0.13 $ 0.61 $ 0.28 $ 0.24 $ 0.12 $ 0.61 $ 0.26
======= ====== ====== ======= ======= ====== ======= ======
</TABLE>
<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
</LEGEND>
<MULTIPLIER> 1000
<CURRENCY> U.S.
<S> <C>
<PERIOD-TYPE> 9-MOS
<FISCAL-YEAR-END> DEC-31-1997
<PERIOD-END> SEP-30-1997
<EXCHANGE-RATE> 1
<CASH> 5,097
<SECURITIES> 3,500
<RECEIVABLES> 7,120
<ALLOWANCES> 185
<INVENTORY> 3,177
<CURRENT-ASSETS> 20,464
<PP&E> 2,795
<DEPRECIATION> 1,427
<TOTAL-ASSETS> 21,897
<CURRENT-LIABILITIES> 2,550
<BONDS> 0
0
100
<COMMON> 55
<OTHER-SE> 0
<TOTAL-LIABILITY-AND-EQUITY> 21,897
<SALES> 15,343
<TOTAL-REVENUES> 15,343
<CGS> 6,684
<TOTAL-COSTS> 5,370
<OTHER-EXPENSES> (281)
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 9
<INCOME-PRETAX> 3,561
<INCOME-TAX> (256)
<INCOME-CONTINUING> 3,817
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> 3,817
<EPS-PRIMARY> 0.61
<EPS-DILUTED> 0.61
</TABLE>
